Doctor Warns of 'Double Covid' Risk as Winter Vaccine Deadline Looms
Doctor Warns of 'Double Covid' Risk as Vaccine Deadline Nears

A leading GP has issued a stark warning about the possibility of contracting 'double Covid' infections, where individuals could catch the virus while still suffering symptoms from a previous bout, potentially even picking up two different strains simultaneously. This caution comes as the UK Health Security Agency (UKHSA) releases figures showing an 11 per cent increase in lab-confirmed Covid cases across the country.

Understanding the 'Double Covid' Phenomenon

GP Dr Nish Manek explained to the BBC that having long Covid does not provide immunity against reinfection. She stated that protection from past infections or vaccinations diminishes over several months, while new variants can evade the immune system's defences. This means even those managing long Covid symptoms remain vulnerable to catching the virus again, which could potentially trigger symptom flare-ups or slow recovery progress.

Dr Manek emphasised that a positive test result could indicate either the same variant or a new one, but regardless, it represents an active Covid infection. She stressed the importance of maintaining protective habits such as testing when unwell, wearing masks in crowded indoor spaces, and keeping up with vaccinations to reduce the risk of serious illness.

Current Covid Landscape in the UK

The latest UKHSA data reveals 51 Covid-related deaths in the week leading up to January 9, with over 500 hospital admissions. As of January 2026, the virus continues to evolve, with the NB.1.8.1 variant, commonly referred to as the "Nimbus" variant, being among the most prevalent strains currently circulating in the UK.

Most Common Symptoms of Current Variants

While many symptoms resemble those of previous Omicron waves, current variants frequently cause upper respiratory issues that can feel similar to severe colds or flu. The most distinguishing features include:

  • "Razor-blade" Sore Throat: A particularly painful, sharp throat sensation
  • Hoarse Voice: Often accompanied by swollen neck glands
  • Congestion: Blocked or runny nose with frequent sneezing
  • Fatigue: Unusual tiredness or feeling "wiped out"
  • Standard Symptoms: High temperature, continuous cough, and body aches remain common

Notably, loss of taste or smell is reported much less frequently than during the pandemic's early stages.

UK Vaccination Strategy: Winter Deadline Approaches

The UK has adopted a more targeted vaccination approach, focusing on those at highest risk of severe illness. With the winter 2025/26 programme concluding shortly, eligible individuals have limited time to receive their dose.

Winter 2025/26 Programme (Ending January 31)

The current winter campaign finishes on January 31, 2026. Eligibility criteria include:

  1. Individuals aged 75 or over (or those turning 75 by January 31, 2026)
  2. Residents in care homes for older adults
  3. Anyone aged 6 months or older who is immunosuppressed due to conditions such as cancer treatment, organ transplants, or specific long-term medications

Spring 2026 Programme (Starting April)

The government has confirmed a spring 2026 booster programme, with bookings typically opening in late March and vaccinations commencing from April 13, 2026. Eligibility remains consistent with the winter programme, targeting:

  • Adults aged 75 and over
  • Residents in care homes for older people
  • Anyone aged 6 months and over who is immunosuppressed

How to Access Your Vaccine

Eligible individuals do not need to wait for formal invitations. They can arrange their vaccination through multiple channels:

  • Booking online via the official NHS website
  • Using the NHS App for convenient scheduling
  • Calling the free 119 helpline
  • Visiting walk-in pharmacies or clinics offering the service

As Covid continues to evolve and circulate within communities, healthcare professionals urge eligible individuals to take advantage of available protection before the winter programme concludes, while preparing for the spring booster initiative that will provide continued defence against emerging variants.